We are live on ! Find out more
JPMIA

J.P. Marvel Investment Advisors Portfolio holdings

AUM $705M
1-Year Est. Return 43.01%
This Fund
S&P 500
This Quarter Est. Return
-2.54%
1 Year Est. Return
+43.01%
3 Year Est. Return
+140.86%
5 Year Est. Return
+213.54%
10 Year Est. Return
–
AUM
$491M
AUM Growth
-$20.3M
Cap. Flow
+$3.31M
Cap. Flow %
0.67%
Top 10 Hldgs %
43.51%
Holding
72
New
2
Increased
18
Reduced
22
Closed
3

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$3.37M
2
MOS icon
The Mosaic Company
MOS
+$1.97M
3
CRL icon
Charles River Laboratories
CRL
+$156K
4
KO icon
Coca-Cola
KO
+$90.4K
5
VZ icon
Verizon
VZ
+$67.1K

Top Sells

Rank Stock Value
1
TTWO icon
Take-Two Interactive
TTWO
+$915K
2
NUAN
Nuance Communications, Inc.
NUAN
+$282K
3
VTRS icon
Viatris
VTRS
+$272K
4
MS icon
Morgan Stanley
MS
+$173K
5
AWK icon
American Water Works
AWK
+$153K

Sector Composition

Rank Sector Weight
1 Healthcare 31.77%
2 Technology 25.93%
3 Financials 12.33%
4 Communication Services 7.23%
5 Consumer Discretionary 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.97T
$37.6M 7.65%
215,251
-453
-0.2% -$76.2K
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$4.12T
$28.9M 5.87%
207,580
-240
-0.1% -$32.6K
NVDA icon
3
NVIDIA
NVDA
$4.6T
$24.8M 5.04%
907,670
-2,350
-0.3% -$58.9K
TMO icon
4
Thermo Fisher Scientific
TMO
$214B
$22.5M 4.58%
38,137
-259
-0.7% -$149K
AMZN icon
5
Amazon
AMZN
$2.44T
$21.9M 4.46%
134,420
– –
MS icon
6
Morgan Stanley
MS
$319B
$18.3M 3.72%
209,133
-1,790
-0.8% -$173K
LLY icon
7
Eli Lilly
LLY
$1.08T
$16.5M 3.35%
57,515
-60
-0.1% -$15.4K
JPM icon
8
JPMorgan Chase
JPM
$916B
$15.2M 3.1%
111,771
-120
-0.1% -$17.7K
V icon
9
Visa
V
$701B
$14.2M 2.89%
63,927
– –
ABBV icon
10
AbbVie
ABBV
$465B
$14M 2.84%
86,100
+95
+0.1% +$13.8K
MSFT icon
11
Microsoft
MSFT
$2.9T
$13.9M 2.82%
44,988
+1
+0% +$301
BMY icon
12
Bristol-Myers Squibb
BMY
$129B
$13.1M 2.67%
179,787
+809
+0.5% +$54.3K
CVS icon
13
CVS Health
CVS
$135B
$12.3M 2.51%
121,627
+186
+0.2% +$19.5K
JNJ icon
14
Johnson & Johnson
JNJ
$640B
$12.2M 2.49%
69,045
-20
-0% -$3.4K
DE icon
15
Deere & Co
DE
$165B
$11.9M 2.41%
28,527
-20
-0.1% -$7.66K
BAC icon
16
Bank of America
BAC
$429B
$11.6M 2.35%
280,627
-420
-0.1% -$18.9K
PFE icon
17
Pfizer
PFE
$143B
$11.5M 2.34%
221,770
+355
+0.2% +$18.4K
AKAM icon
18
Akamai
AKAM
$15.6B
$10.6M 2.17%
89,171
-150
-0.2% -$16.8K
CSCO icon
19
Cisco
CSCO
$443B
$10.5M 2.14%
189,010
+312
+0.2% +$17.7K
CRL icon
20
Charles River Laboratories
CRL
$11.3B
$10.3M 2.1%
36,325
+507
+1% +$156K
GLW icon
21
Corning
GLW
$107B
$9.54M 1.94%
258,570
+369
+0.1% +$14.4K
LRCX icon
22
Lam Research
LRCX
$316B
$9.12M 1.86%
169,640
– –
EOG icon
23
EOG Resources
EOG
$77.7B
$8.72M 1.77%
73,120
– –
ABT icon
24
Abbott
ABT
$188B
$8.39M 1.71%
70,918
– –
MRNA icon
25
Moderna
MRNA
$21.6B
$8.01M 1.63%
46,518
-135
-0.3% -$22.7K
1
2 3

Similar funds

GHCMRT
Graham Holdings Co Master Retirement Trust Arlington, Virginia $706M AUM 7.7% 1-Year Est. Return
IFM
ION Fund Management Herzliya $707M AUM
TWM
TRB Wealth Management Houston, Texas $704M AUM
SSCM
Summit Street Capital Management New York $707M AUM 76.8% 1-Year Est. Return
NG
Northstar Group New York $707M AUM 11.67% 1-Year Est. Return
SC
Shellback Capital Boston, Massachusetts $703M AUM 53.29% 1-Year Est. Return
KM
Kora Management Brooklyn, New York $702M AUM 17.03% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return

J.P. Marvel Investment Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, J.P. Marvel Investment Advisors held 72 positions worth $491M, down 4% from $512M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

J.P. Marvel Investment Advisors's Q1 2022 filing shows 2 new, 18 increased, 22 reduced and 3 closed positions. Its largest new stake was Intra-Cellular Therapies Inc.: 64,858 shares worth $3.97M. The largest sale was Take-Two Interactive, an estimated $915K.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

  • J.P. Marvel Investment Advisors's largest Q1 2022 buy was Intra-Cellular Therapies Inc.: 64,858 shares worth $3.97M.
  • J.P. Marvel Investment Advisors added most to Charles River Laboratories in Q1 2022, an estimated $156K increase.
  • J.P. Marvel Investment Advisors's biggest Q1 2022 reduction was Morgan Stanley, cutting an estimated $173K.
  • J.P. Marvel Investment Advisors fully exited Take-Two Interactive in Q1 2022, selling an estimated $915K.
  • J.P. Marvel Investment Advisors's ten largest holdings make up 44% of its $491M portfolio in Q1 2022.
  • J.P. Marvel Investment Advisors opened 2 new positions and closed 3 in Q1 2022.
  • J.P. Marvel Investment Advisors's portfolio value fell 4% quarter-over-quarter to $491M.

Based on J.P. Marvel Investment Advisors's 13F filing for Q1 2022, filed 12 May 2022.